MIDAS®

Achieve Commercial Excellence with Harmonized Global Market Intelligence

Experience the gold standard in pharmaceutical market measurement with
IQVIA MIDAS®, now enhanced with patient insights by disease for deeper market analysis. All accessible in minutes with agentic AI.

Analyze market performance from sales to disease and patient

IQVIA MIDAS® has long been considered the industry benchmark for global market measurement, integrating the breadth and depth of IQVIA's unparalleled data assets with advanced analytics and deep domain expertise across 95 countries.

The newly launched MIDAS Patient adds patient insights across 600 diseases at scale supporting the industry shift towards multi-indication drugs and patient-centricity.

With IQVIA Global Market Insights (GMI) Agent, powered by agentic AI, these insights are now accessible in minutes, enabling faster and smarter decision-making.

More about Disease & Patient-level Insights

Dig deeper and add a disease dimension to your market analyses and identify new opportunities

Hyper-segment your market and competitive landscape by 600+ diseases and 35 tumors with MIDAS Disease.

MIDAS Disease sources optimal syndicated disease segmentation inputs from across IQVIA and seamlessly integrates them with harmonized sales data to provide drug-by-disease insights and total disease market sizing for the entire MIDAS universe.

NEW: Catalyze organizational growth with Patient-Centric Intelligence

Quantify estimated drug-treated patients and associated measures by drugs and diseases at-scale with MIDAS Patient.

MIDAS Patient revolutionizes market measurement by delivering comprehensive patient insights across all MIDAS-covered markets and products, fully harmonized for cross-country comparison. It integrates patient dynamics with disease metrics, allowing you to unravel complex patient landscapes.

With MIDAS Patient, quantify drug-treated patients across:

95

Countries

600

Diseases including 35 tumors

1.6M

Products

4M

Packs

Make data-driven decisions that improve outcomes and drive business growth

Measure and manage market performance across the brand mix

  • Market size and share analysis 
  • Budgeting and planning 
  • Market segmentation - geography, channel, disease, indication
  • Competitor analysis
  • Launch strategy, pre-launch market monitoring, launch assessment 
  • Patient dynamics 
  • Market landscaping to support HCP targeting 
  • Patient-metrics supported brand promotion 
  • Biosimilars market dynamics measurement

Align portfolio decisions with patient needs and market dynamics

  • Global lifecyle and LoE strategy
  • Therapy and franchise expansion opportunities
  • Market/therapy/brand forecasting
  • Global franchise commercial strategy
  • Portfolio growth opportunities supplemented by integrated patient insights with disease metrics

Drive organizational strategy with disease and patient-centric intelligence

  • Geographical footprint and prioritization
  • Investment planning and allocation
  • M&A and divestment
  • Forecasting and planning
  • Corporate reporting
  • Price and value proposition
  • Long-term disease strategy optimization
  • Patient-centric decision-making 
  • Demand/supply chain planning for new innovations

Evaluate clinical use and commercial potential

  • Clinical Strategy and operations
  • Regional Clinical Trials set-up
  • Emerging treatment trends identification
  • Patient treatment patterns evaluation
IQVIA Global Market Insights Agent
Transform global market data into strategy in minutes with agentic AI
Accessing MIDAS via our newly launched IQVIA Global Market Insights (GMI) Agent transforms market insights by leveraging advanced natural language processing. This innovative tool will help you analyze market shifts, accelerate insights generation, and deliver global intelligence in minutes. Experience the next evolution in pharmaceutical strategy where AI-powered decisions fuel your success.

KEY BENEFITS:

IMMEDIATE INSIGHTS: Generate real-time insights through AI-powered analytics, automated visualizations, and concise trend summaries.

ENHANCED DATA ACCESSIBILITY: Effortlessly explore complex pharma market data and convert it into actionable strategies.

COMPETITIVE ADVANTAGE: Stay ahead of competitors by capturing market share and driving growth with authoritative data.

STRATEGIC DECISION-MAKING: From brand performance to growth dynamics, make informed strategic decisions with depth and precision.
Request a demo
Ready to take control of critical market dynamics?
Discover how our unparalleled patient data can revolutionize your approach to market analysis and give you the edge you need to succeed.

Schedule a demo or speak with one of our experts today

Webinar

Revealing Pharma Trends Through Drug-Treated Patient Insights

In this thought-provoking session, we'll examine key global market trends through patient numbers, revealing surprising trends. For example, while respiratory treatments rank 4th in volume, they lead the way in terms of patient numbers (taking prescription medicines). Through a demonstration of MIDAS Patient, we'll showcase how these patient-centric insights can drive strategic decision-making across the pharmaceutical industry.

Don't miss this opportunity to discover how cutting-edge patient analytics are transforming market analysis, offering a more comprehensive view of the evolving pharmaceutical landscape. Amplify your market understanding to gain a decisive advantage in navigating complex markets.

ON DEMAND WEBINAR

Explore 2024 industry trends and pharma outlooks for 2025

Watch this webinar to review key pharma metrics for 2024, understand driving forces behind current healthcare market challenges and discover strategies to overcome them.

  • Get an overview of global Market Trends for 2024 including:
    • Sales value and volume, therapy area split, promotion mix
    • Launch environment performance
  • Deep dive into the Oncology, Immunology and Obesity markets looking at key trends, innovations and developments, including an overview of patient dynamics.
  • Review the current Biosimilar uptake

Related solutions

Contact Us